Alignment Health Plan announced the launch of Central Health Harmony, a new Medicare Advantage plan tailored for Asian American seniors in Los Angeles and Orange counties, effective January 1, 2027. The plan features access to over 600 Chinese-, Korean-, and Vietnamese-speaking physicians, culturally tailored benefits including enhanced acupuncture coverage, in-language support, and grocery allowances at Asian specialty markets. The plan partners with leading providers including Astrana Health and Hoag Health System.

Astrana Health (ASTH) is expected to beat earnings estimates again based on its strong track record of earnings surprises. The company has averaged a 92.10% surprise rate over the last two quarters, with a +12.78% Earnings ESP and Zacks Rank #3 (Hold), suggesting another potential beat is likely.

Alignment Health Plan announced expansion into Kern, Kings, and Tulare counties in California's Central Valley and added Hoag and Astrana Health to its provider network for 2027. The expansion will bring coverage to 25 California counties serving over 6.3 million Medicare beneficiaries, with 46 Medicare Advantage plans offering premiums as low as $0 and specialized plans for chronic conditions.

Pomerantz LLP is investigating potential securities fraud claims against Astrana Health, Inc. following a Glass House Research short report alleging aggressive acquisitions, subjective management estimates, concerns over a $545 million related-party loan, and 2027 Medicare regulatory exposure. The stock fell 9.02% to $34.30 per share on September 17, 2026.

The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.

Astrana Health reported strong Q2 2025 financial results with total revenue of $654.8 million, up 35% year-over-year, and completed its acquisition of Prospect Health, expanding its healthcare service platform.

Astrana Health, Inc. (ASTH) possesses solid growth attributes, which could help it handily outperform the market.

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 21.43% and 2.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 4.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Truist Securities has decided to maintain its Hold rating of Astrana Health (NASDAQ:ASTH) and raise its price target from $41.00 to $44.00. Shares of Astrana Health are trading down 1.44% over the last 24 hours, at $44.39 per share. A move to $44.00 would account for a 0.88% decrease from the current share price. About Astrana Health Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based ...Full story available on Benzinga.com

Astrana Health Inc. (ASTH) delivered earnings and revenue surprises of 52.94% and 1.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?